What is Adial Pharmaceuticals Inc (ADIL) stock price today?

Adial Pharmaceuticals Inc (ADIL) currently trades at $1.55 per share. The stock has a market capitalization of $2.21M and a P/E ratio of —x.

Is ADIL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Adial Pharmaceuticals Inc has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -24.63.

Is Adial Pharmaceuticals Inc financially healthy?

Adial Pharmaceuticals Inc's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -24.63 places it in the distress.

ADIL

Adial Pharmaceuticals Inc

NASDAQ: ADIL · HEALTHCARE · BIOTECHNOLOGY

$1.55

-0.64% today

Updated 2026-04-29

Market cap

$2.21M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-11.93

Dividend yield

—

52W range

$2 – $30

Volume

0.1M

Market cap

$2.21M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-11.93

Dividend yield

—

52W range

$2 – $30

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.3

Quality

C+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-24.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$25.00

+1512.90%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -24.63 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.32M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-12.73M	$-7.00M	$-13.20M	$-7.98M	$-2.00M
EPS	—	—	—	—	$-11.93
Free cash flow	$-11.19M	$-13.61M	$-6.92M	$-6.49M	$-1.32M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ADIL	$2.21M	26	4.3	3.0	5.0	5.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Adial Pharmaceuticals Inc trades at $1.55. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -24.63, it sits in the distress.

Frequently asked questions

What is Adial Pharmaceuticals Inc's stock price?

Adial Pharmaceuticals Inc (ADIL) trades at $1.55.

Is Adial Pharmaceuticals Inc overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Adial Pharmaceuticals Inc (ADIL)?

The analyst target price is $25.00, representing +1512.9% upside from the current price of $1.55.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-24.63 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.adial.com

Quick metrics

P/S ratio—

ROE-170.70%

Beta1.40

50D MA$1.87

200D MA$6.56

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ADIL vs LLY →ADIL vs JNJ →ADIL vs ABBV →Stock screener →